Filtros: Autor es Alguacil, J [Restablecer todos los filtros]
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36.
CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Digestive diseases and sciences. 2008;53(5):1417-21.
Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704.